PLBD1 and glioma: According to Figure 3F–3N, the overexpression of 7 NRLs (MIR210HG, LINC01503, CRNDE, HOXC-AS1, ZIM2-AS1, MIR22HG and PLBD1-AS1) was associated with a poor prognosis for glioma patients.